Skip to Content
MilliporeSigma
All Photos(1)

Key Documents

11271164001

Roche

Interleukin-2, mouse (mIL-2)

recombinant (E. coli)

Synonym(s):

mIL-2, mouse interleukin-2

Sign Into View Organizational & Contract Pricing


About This Item

UNSPSC Code:
12352207

biological source

mouse

Quality Level

recombinant

expressed in E. coli

assay

>95% (SDS-PAGE)

form

solution

potency

<0.5 ng/mL EC50

mol wt

17,200 Da

packaging

pkg of 10,000 U (5 μg, 1 ml)

manufacturer/tradename

Roche

storage condition

avoid repeated freeze/thaw cycles

technique(s)

inhibition assay: suitable

impurities

<0.1 EU/μgtested (LAL test)

UniProt accession no.

storage temp.

−20°C

Gene Information

mouse ... Il2(16183)

General description

Contents: 10,000 U/ml solution in PBS and 1 mg/ml BSA, filtered through a 0.2 μm pore size membrane
Interleukin-2 (IL-2, also known as T-cell growth factor, TCGF) is a lymphokine produced by lectin- or antigen-activated T-cells. It plays an important immunoregulatory role. This factor was first identified by its ability to promote the long-term in vitro proliferation of activated T-cells. It also promotes the generation and proliferation of cytotoxic T-cells, natural killer (NK) cells, and lymphokine-activated killer (LAK) cells. IL-2 also induces other lymphokines such as interferon-γ and B-cell growth factor (BCGF-1).
Recombinant Interleukin-2, mouse (mIL-2), is produced in E. coli and purified by standard chromatographic methods.

Specificity

Mouse IL-2 is effective on mouse cells, but not on human cells.

Application

Recombinant murine IL-2 is produced in E. coli and exhibits the following:
  • Supports the growth of murine CTLL cells (murine T cell line), but not that of human T-cells.
  • Strongly inhibits the binding of recombinant human IL-2 to murine responder cells.
  • Weakly inhibits the binding to human responder cells.
  • Shares identical biological and immunological activities with human IL-2.
  • Is a convenient tool for extensive studies of the pharmacological and physiological activities of IL-2 in murine models.
  • used for the stimulation of murine T-cells

Quality

Endotoxin level: <0.1 EU/μg (LAL-test), <10 EU/ml (LAL-test)

Sequence

Chain Length 149 AA
One polypeptide chain (149 amino acids), identical to natural mouse IL-2, but not glycosylated. Glycosylation is not essential for biological activity.

Unit Definition

EC50 definition: The amount of mIL-2 that is required to support half-maximal stimulation of cell proliferation (XTT cleavage) with CTLL-2 cells (1 unit equals ≤0.5 ng).

Preparation Note

Working solution: Dilute the concentrated IL-2 solution (10,000 U/ml) with PBS or culture medium containing 1 mg/ml BSA [or HSA (human serum alburnin)], or 1 to 10% serum (v/v).
Storage conditions (working solution): -15 to -25 °C
Note: Avoid repeated freezing and thawing.

Other Notes

Specific activity/EC 50: >2 x 106 U/mg, <0.5 ng/ml (hIL-2, NIBSC, 1st international standard, 86/504), at least the same specific activity (EC50) compared to the indicated standard is guaranteed.
Note: The biological activity of this product may vary in different in vitro applications. Determine the optimal concentration range for specific applications.
EC 50 definition/Unit definition: The amount of mIL-2 that is required to support half-maximal stimulation of cell proliferation (XTT cleavage) with CTLL-2 cells (1 unit equals =0.5 ng).
For life science research only. Not for use in diagnostic procedures.

Storage Class

12 - Non Combustible Liquids

wgk_germany

nwg

flash_point_f

No data available

flash_point_c

No data available


Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

James Lee et al.
Methods in molecular biology (Clifton, N.J.), 506, 83-96 (2008-12-27)
In comparison to human T cells, efficient retroviral gene transfer and subsequent expansion of murine primary T cells is more difficult to achieve. Herein, we describe an optimized gene transfer protocol utilizing an ecotropic viral vector to transduce primary murine
Bergren W Crute et al.
Frontiers in immunology, 11, 592329-592329 (2020-11-17)
Among the areas of most impactful recent progress in immunology is the discovery of inhibitory receptors and the subsequent translation of this knowledge to the clinic. Although the original and canonical member of this family is FcγRIIB, more recent studies
Massimo Martinelli et al.
iScience, 26(1), 105860-105860 (2023-01-13)
The RNA-binding protein Pcbp2 is widely expressed in the innate and adaptive immune systems and is essential for mouse development. To determine whether Pcbp2 is required for CD4+ T cell development and function, we derived mice with conditional Pcbp2 deletion in
Anastasiia Kalinina et al.
STAR protocols, 2(1), 100368-100368 (2021-03-23)
Adoptive transfer therapy has great potential to treat diseases such as cancer as well as autoimmune and infectious diseases. Identification of chain-centric T cell receptors (TCRs) with the dominant-active antigen-specific α-chains (TCRα) can significantly improve the efficacy of adoptive cell therapy
Ping-Wei Zhao et al.
Mediators of inflammation, 2015, 762709-762709 (2015-04-22)
This study aimed to assess the differential expression of specific B cell subtypes in patients with chronic viral hepatitis. The frequencies of differential expression of specific B cell subtypes in patients with chronic viral hepatitis and healthy controls were assessed

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service